No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)
Academic Article
Publication Date:
2014
Short description:
Sainato, A., Cernusco Luna Nunzia, V., Valentini, V., De Paoli, A., Maurizi, E., Lupattelli, M., Aristei, C., Vidali, C., Conti, M., Galardi, A., Ponticelli, P., Friso, M., Iannone, T., Osti, F., Manfredi, B., Coppola, M., Orlandini, C., Cionini, L., No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT), <>, 2014; 113 (2): 223-229. [doi:10.1016/j.radonc.2014.10.006] [http://hdl.handle.net/10807/63792]
abstract:
To evaluate the effect of adjuvant chemotherapy (ACT) in locally advanced rectal cancer (LARC) after neoadjuvant chemoradiation (NACT-RT). The study was funded by the Italian National Research Council (CNR).
Iris type:
Articolo in rivista, Nota a sentenza
Keywords:
Adjuvant chemotherapy; Preoperative radiochemotherapy; Rectal cancer
List of contributors:
Sainato, A; Cernusco Luna Nunzia, V; Valentini, Vincenzo; De Paoli, A; Maurizi, Er; Lupattelli, M; Aristei, C; Vidali, C; Conti, M; Galardi, A; Ponticelli, P; Friso, Ml; Iannone, T; Osti, Fm; Manfredi, B; Coppola, M; Orlandini, C; Cionini, L.
Published in: